Details for Patent: 8,652,492
✉ Email this page to a colleague
Which drugs does patent 8,652,492 protect, and when does it expire?
Patent 8,652,492 protects TAVALISSE and is included in one NDA.
This patent has thirty-seven patent family members in thirty-two countries.
Summary for Patent: 8,652,492
Title: | Wet granulation using a water sequestering agent |
Abstract: | Disclosed are tablets comprising hydrolytically stable formulations of (6-(5-fluoro-2-(3,4,5-trimethoxyphenylamino)pyrimidin-4-ylamino)-2,2-dime- thyl-3-oxo-2H-pyrido[3,2-b][1,4]oxazin-4(3H)-yl)methyl phosphate disodium salt (Compound 1) prepared by a wet granulation process. |
Inventor(s): | Sun; Thomas (Palo Alto, CA), Lo; Ray J. (San Leandro, CA) |
Assignee: | Rigel Pharmaceutical, Inc. (South San Francisco, CA) |
Application Number: | 13/738,458 |
Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 8,652,492 |
Patent Claim Types: see list of patent claims | Use; Composition; Formulation; Compound; Dosage form; |
Drugs Protected by US Patent 8,652,492
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Rigel Pharms Inc | TAVALISSE | fostamatinib disodium | TABLET;ORAL | 209299-001 | Apr 17, 2018 | RX | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | ||||
Rigel Pharms Inc | TAVALISSE | fostamatinib disodium | TABLET;ORAL | 209299-002 | Apr 17, 2018 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 8,652,492
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Australia | 2008323938 | ⤷ Try a Trial | |||
Brazil | PI0820389 | ⤷ Try a Trial | |||
Canada | 2704474 | ⤷ Try a Trial | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |